26 April 2016 : Review article
Evaluation of Treatment with a Combination of Everolimus and Low-Dose Cyclosporine A in De Novo Pediatric Kidney Transplantation Patients: A Systematic ReviewJun WangEF, Nannan GuAB, Mingming YuC, Jingtong ShaD, Hang WuD, Yulong GongC, Haobo ZhuCD, Zheng GeCD, Rugang LuD, Gemg MaBC, Yunfei GuoEG
Med Sci Rev 2016; 3:49-54
The aim of our systematic review was to determine the clinical efficacy, safety, and tolerability of everolimus and low-dose cyclosporine A (CsA) combination treatment in de novo pediatric kidney transplantation. Our electronic literature searches of Medline, Cochrane Central Register of Controlled Trials (CENTRAL) and Embase (updated on May 1st 2015) checked all articles on everolimus and low-dose CSA treatment published in English language. Two authors independently made study selections, data extraction, and analysis. A total of 3 case series and 3 clinical trials were included in our systematic review. The overall incidence rate of borderline changes, biopsy-proven acute rejection, interstitial fibrosis, and tubular atrophy, graft loss and death were 8.21%, 9.00%, 13.43%, 0.75%, and 0%, respectively. The incidence rate of urinary tract infection was 30.83%, but can be well-tolerated by giving proper medical treatment. Other reported severe adverse events, such as lymphocele, wound healing dysfunction, pyrexia, pneumonia, viral infections, were less than 10%. Everolimus and low-dose CsA combination treatment is effective, safe, and well-tolerated in de novo pediatric kidney transplantation. However, an open-label randomized controlled clinical trial will provide an incentive to refine our clinical use of everolimus in children.
Keywords: Cyclosporine, Hospitals, Pediatric, Kidney Transplantation
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952